Industry focus: healthcare and life sciences

Loyens & Loeff

Loyens & Loeff is known for handling a broad range of matters in the healthcare and life sciences arena, including advising on clinical trials, investments, procurement cases and competition issues. Kim Lucassen leads the firm's data protection and privacy practice and is active in life sciences and healthcare matters; she co-heads the department with Vincent van der Lans, a key contact for M&A work and multi-jurisdictional restructurings, and the 'highly skilled' Tom van Helmond, who handles a wide spectrum of procurement and competition law issues. Dieuwke Hooft Graafland's 'knowledge of legislation in her field of expertise is remarkable'. Hamza Zourakhti left the firm in September 2024.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

‘Dieuwke Hooft-Graafland's knowledge of legislation in her field of expertise is remarkable.’
‘Loyens & Loeff provides a high quality of service. The lawyers are specialists in their field.’
‘The team is highly knowledgeable in healthcare and life sciences.’
‘The experts at Loyens & Loeff are accessible, committed, trustworthy and effective. Tom van Helmond and Dieuwke Hooft Graafland are outstanding.’
‘Dieuwke Hooft Graafland is a great lawyer. She is very experienced and keeps her eye on the bigger picture. She delivers on time.’
‘The Healthcare and Life Sciences practice has consistently demonstrated a deep understanding of the unique challenges and opportunities within the life sciences and healthcare industry, offering tailored advice that balances legal expertise with industry knowledge. Their multidisciplinary team combines legal, regulatory, and tax expertise, enabling them to provide integrated solutions that address the full spectrum of challenges in healthcare and life sciences. They have a strong track record of navigating complex regulatory environments, both at national and EU levels.'
‘Tom van Helmond is a highly skilled expert within the Healthcare and Life Sciences team, and what truly makes him exceptional is his combination of technical legal expertise and a deep understanding of the intricacies of the industry. What makes Tom different from others in the field is his commitment to truly understanding his clients' needs. He doesn’t just provide legal advice; he takes the time to learn the nuances of your business and the sector in which you operate, ensuring that his counsel is practical and directly applicable to your goals.'

Key clients

AstraZeneca
Zilveren Kruis
Unilabs
Bergman Clinics
Zorgverzekeraars Nederland
European Investment Bank
Forbion
VGZ
Laurens
Unilabs
EQT
Menzis
Amstelland Hospital
Medtronic
Orpea
Galapagos
CZ
PRA International
Orpea

Work highlights

Advised Eurazeo S.A on the sale of medical technology company DORC to German company Carl Zeiss Meditec AG.
Advising healthcare insurers on a range of legal matters concerning the bankruptcy of Co-Med.
Advised the Orpea Group on restructuring and healthcare regulatory aspects in the Netherlands.

Lawyers

Hall of Fame

The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.